2017 OUR EXPERTS

- Archives -

Clinical trial of ketamine for treatment-resistant depression underway at UMass Medical School

Clinical trial of ketamine for treatment-resistant depression underway at UMass Medical School

UMass Medical School depression expert Anthony Rothschild, MD, is conducting a clinical trial of ketamine for patients with treatment-resistant depression.

Expert’s Corner: Javier Irazoqui researches communication between the gut and the nervous system

Expert’s Corner: Javier Irazoqui researches communication between the gut and the nervous system

Javier Elbio Irazoqui, PhD, associate professor of microbiology & physiological systems, is interested in fundamental mechanisms of innate immunity and inflammation.

Rachel Gershon in STAT: States may drive future of national health care reform

Rachel Gershon in STAT: States may drive future of national health care reform

Health care reform may now lay with states, which can use federal waivers to change the Affordable Care Act and Medicaid with less fanfare than efforts that originate in Washington, D.C., according to UMass Medical School health care law and policy expert Rachel Gershon, JD, MPH, in an opinion piece for STAT. 

Expert’s Corner: Mark Johnson studies a treatable brain disorder that often goes undiagnosed

Expert’s Corner: Mark Johnson studies a treatable brain disorder that often goes undiagnosed

Mark D. Johnson, MD, PhD, chair and professor of neurosurgery, studies normal pressure hydrocephalus (NPH), and is focused on developing a simple, readily accessible test to identify patients who have it. 

Neil Aronin studies gene silencing to treat Huntington’s disease

Neil Aronin studies gene silencing to treat Huntington’s disease

In this Expert's Corner video, Neil Aronin, MD, professor of medicine, co-director of the Neurotherapeutics Institute and a globally recognized leader in the field, talks about exploring a promising new therapeutic approach to Huntington's disease based on gene silencing or RNA interference.

Chancellor Collins: In Trump economy, federal research dollars must be protected

Chancellor Collins: In Trump economy, federal research dollars must be protected

Chancellor Michael F. Collins told the Worcester Business Journal Economic Forecast Forum on Thursday, Feb. 16, of his concern that the National Institutes of Health funding—critical to UMass Medical School as well as the local economy and the future of science and medicine nationwide—could suffer under the Trump administration.

Stay Connected with UMassMedNow

For the Media
▴ Back To Top
Section Menu To Top